FrancophonIA/ELRC3.0 huggingface dataset:
English: General disorders and administration site conditions pyrexia, rigors injection site thrombosis, infusion site inflammation, injection site pain, peripheral oedema
Slovenian: Splošne težave in spremembe na mestu aplikacije pireksija, mrzlica tromboza na mestu injiciranja, vnetje na mestu infundiranja,
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGING CARTON
Slovenian: PODATKI NA ZUNANJI OVOJNINI ŠKATLA ŠKATLA
English: Mycamine is effective in treating systemic infections (those that have penetrated within the body).
Slovenian: Zdravilo Mycamine učinkovito zdravi sistemske okužbe (okužba, ki je zajela večji del organizma), tako da ovira nastajanje dela celične stene gliv.
English: Hepatobiliary disorders common hyperbilirubinaemia, hepatomegaly
Slovenian: Bolezni jeter, žolčnika in žolčevodov pogosti hiperbilirubinemija, hepatomegalija
English: Micafungin was not mutagenic or clastogenic when evaluated in a standard battery of in vitro and in vivo tests, including an in vitro study on unscheduled DNA synthesis using rat hepatocytes.
Slovenian: Pri standardnih in vitro in in vivo testih, vključno z in vitro študijo na neurejeni sintezi DNA z uporabo hepatocitov podgan, mikafungin ni pokazal mutagenih ali klastogenih učinkov.
English: In rats, vacuolation of the renal pelvic epithelium as well as vacuolation and thickening (hyperplasia) of the bladder epithelium were observed in 26-week repeat dose studies.
Slovenian: V 26-tedenski študiji ponavljajočih odmerkov so pri podganah opazili vakuolizacijo epitelija v ledvičnem mehu ter vakuolizacijo in zadebelitev (hiperplazijo) epitelija v mehurju.
English: In dog, liver effects consisted of increased weight and centrilobular hypertrophy, no degenerative changes of hepatocytes were observed.
Slovenian: Pri psih so učinki vključevali povečanje njihove mase in centrolobularno hipertrofijo.
English: - The dose to treat a Candida infection of the oesophagus is 150 mg for patients weighing more than 40 kg and 3 mg/kg per day for patients weighing 40 kg or less.
Slovenian: - Odmerek za zdravljenja okužbe požiralnika s kandido je 150 mg za bolnike s telesno maso nad 40 kg in 3 mg/kg za bolnike s telesno maso 40 kg ali manj.
English: - The usual dose to treat an invasive Candida infection is 100 mg per day for patients weighing 40 kg or more and 2 mg/kg per day for patients weighing 40 kg or less.
Slovenian: - Običajni odmerek za zdravljenje invazivne okužbe s kandido je 100 mg na dan za bolnike s telesno maso 40 kg ali več in 2 mg/kg za bolnike s telesno maso 40 kg ali manj.
English: Renal and urinary disorders common acute renal failure, blood urea increased
Slovenian: Bolezni sečil pogosti akutna ledvična odpoved, povečana vrednost sečnine v krvi
English: Mycamine 50 mg powder for solution for infusion Mycamine 100 mg powder for solution for infusion
Slovenian: Mycamine 50 mg prašek za raztopino za infundiranje Mycamine 100 mg prašek za raztopino za infundiranje
English: aggravated kidney failure - increase in an enzyme called lactate dehydrogenase - clotting in vein at injection-site; inflammation at injection-site; pain at injection-site; collection of fluid in your body
Slovenian: - strjevanje krvi v veni na mestu injiciranja, vnetje na mestu injiciranja, bolečina na mestu injiciranja, kopičenje tekočine v telesu
English: Your doctor monitors your response and condition to determine what dose of Mycamine is needed.
Slovenian: Če ste dobili večji odmerek zdravila Mycamine, kot bi smeli Zdravnik spremlja vaš odziv in vašo bolezen ter glede na to določi, kolikšen odmerek zdravila Mycamine potrebujete.
English: Astellas Pharmaceuticals AEBE Tηλ: +30 210 8189900
Slovenian: Ελλάδα Tηλ: +30 210 8189900
English: MANUFACTURER(S) RESPONSIBLE FOR BATCH RELEASE
Slovenian: IZDELOVALCI ODGOVORNI ZA SPROŠČANJE SERIJ
English: Talk to your doctor or pharmacist before using Mycamine - if you are allergic to any medicine - if you have haemolytic anaemia (anaemia due to breakdown of red blood cells) or haemolysis
Slovenian: Pred začetkom uporabe zdravila Mycamine se posvetujte z zdravnikom ali farmacevtom: - če ste alergični na katero koli zdravilo.
English: Common (may affect up to 1 in 10 people) - abnormal blood tests (decreased white blood cells [leucopenia; neutropenia]); decreased red blood cells (anaemia) - decreased potassium in the blood (hypokalaemia); decreased magnesium in the blood
Slovenian: Občasni (pojavijo se lahko pri največ 1 od 100 bolnikov) - nenormalne krvne preiskave (zmanjšano število krvničk [pancitopenija]), zmanjšano število trombocitov (trombocitopenija), povečano število nekaterih vrst belih krvničk, imenovanih eozinofilci, zmanjšana vrednost albumina v krvi (hipoalbuminemija)
English: decreased albumin in the blood (hypoalbuminaemia) - hypersensitivity - increased sweating - decreased sodium in the blood (hyponatraemia); increased potassium in the blood
Slovenian: zmanjšano število rdečih krvničk (anemija) - zmanjšana količina kalija v krvi (hipokaliemija), zmanjšana količina magnezija v krvi
English: Skin and subcutaneous tissue disorders rash urticaria, pruritus, erythema toxic skin eruption, erythema multiforme, StevensJohnson syndrome, toxic epidermal necrolysis (see section 4.4)
Slovenian: multiformni eritem, Stevens-Johnsonov sindrom, toksična epidermalna nekroliza (glejte poglavje 4.4)
English: 150 1 x 100 + 1 x
Slovenian: 1 x 100 + 1 x 50 5 ml približno 10 ml
English: An intact cell wall is necessary for the fungus to continue living and growing.
Slovenian: Glive za življenje in rast potrebujejo nepoškodovano celično steno.
English: Experience with Mycamine in patients less than 2 years of age is limited.
Slovenian: mlajših od dveh let, je malo.
English: Mycamine 100 mg powder for solution for infusion micafungin
Slovenian: Mycamine 100 mg prašek za raztopino za infundiranje mikafungin
English: Chemical and physical in-use stability have been demonstrated for 96 hours at 25°C when protected from light and diluted as described above.
Slovenian: Kemična in fizikalna stabilnost med uporabo sta dokazani za 96 ur pri temperaturi 25 °C,
English: Mycamine 50 mg powder for solution for infusion micafungin
Slovenian: Mycamine 50 mg prašek za raztopino za infundiranje mikafungin
English: In adult dogs, atrophy of seminiferous tubules with vacuolation of the seminiferous epithelium and decreased sperm in the epididymides were noted after prolonged treatment (39 weeks) but not after 13 weeks of treatment.
Slovenian: Pri dolgotrajnem zdravljenju (39 tednov), toda ne po 13. tednih, so pri odraslih psih opazili atrofijo seminifernih tubulov z vakuolacijo seminifernega epitelija in zmanjšanje števila spermijev v obmodku.
English: Uncommon (may affect up to 1 in 100 people) - abnormal blood tests (decreased blood cells [pancytopenia]); decreased blood platelets
Slovenian: Pogosti (pojavijo se lahko pri največ 1 od 10 bolnikov) - nenormalne krvne preiskave (zmanjšano število belih krvničk [levkopenija, nevtropenija]),
English: Package leaflet: Information for the user Mycamine 50 mg powder for solution for infusion Mycamine 100 mg powder for solution for infusion micafungin
Slovenian: Navodilo za uporabo Mycamine 50 mg prašek za raztopino za infundiranje Mycamine 100 mg prašek za raztopino za infundiranje mikafungin
English: See section 4.
Slovenian: NAVODILA ZA UPORABO 16.
English: - shortness of breath - indigestion; constipation - liver failure; increased liver enzymes (gamma-glutamyltransferase); jaundice (yellowing of the skin or whites of the eyes caused by liver or blood problems); reduced bile reaching the intestine
Slovenian: - jetrna odpoved, povečana vrednost jetrnih encimov (gama-glutamiltransferaze), zlatenica (porumenelost kože ali beločnic, ki jo povzročijo težave z jetri ali krvjo), zmanjšano izločanje žolča v črevo (holestaza), povečana jetra, vnetje jeter - srbeč izpuščaj (koprivnica), srbenje, rdečica (eritem) - nenormalne preiskave ledvičnega delovanja (povečana vrednost kreatinina v krvi, povečana vrednost sečnine v krvi), poslabšanje ledvične odpovedi
English: Each vial contains: 100 mg micafungin (as sodium).
Slovenian: Ena viala vsebuje: 100 mg mikafungina (v obliki natrijeve soli).
English: - has history of haemolysis, haemolytic anaemia or renal impairment.
Slovenian: - če imate hemolitično anemijo (anemijo zaradi razpadanja eritrocitov) ali hemolizo (razpadanje eritrocitov).
English: Each vial contains 100 mg micafungin (as sodium).
Slovenian: Ena viala vsebuje 100 mg mikafungina (v obliki natrijeve soli).
English: - The usual dose to treat an invasive Candida infection is 4-10 mg/kg per day.
Slovenian: Uporaba pri otrocih in novorojenčkih < 4 mesece - Običajni odmerek za zdravljenje invazivne okužbe s kandido je 4-10 mg/kg na dan. - Običajni odmerek za preprečevanje invazivnih okužb s kandido je 2 mg/kg na dan.
English: Symptoms such as rash and rigors have been reported in clinical studies.
Slovenian: V kliničnih študijah so poročali o simptomih, kot sta izpuščaj in mrzlica.
English: After reconstitution each ml contains 20 mg micafungin (as sodium).
Slovenian: Po pripravi raztopine vsebuje 1 ml raztopine 20 mg mikafungina (v obliki natrijeve soli).
English: Each vial contains: 50 mg micafungin (as sodium).
Slovenian: Ena viala vsebuje: 50 mg mikafungina (v obliki natrijeve soli).
English: Vascular disorders phlebitis hypotension, hypertension, flushing shock
Slovenian: Žilne bolezni flebitis hipotenzija,
English: Hepatic impairment
Slovenian: Psihiatrične motnje nespečnost,
English: Treatment of oesophageal candidiasis
Slovenian: Zdravljenje kandidoze požiralnika
English: Each vial contains 50 mg micafungin (as sodium).
Slovenian: Ena viala vsebuje 50 mg mikafungina (v obliki natrijeve soli).
English: After reconstitution each ml contains 10 mg micafungin (as sodium).
Slovenian: Po pripravi raztopine vsebuje 1 ml raztopine 10 mg mikafungina (v obliki natrijeve soli).
English: The development of foci of altered hepatocytes (FAH) and hepatocellular tumours after a treatment period of 3 months or longer were observed in rats.
Slovenian: Pri podganah, ki so zdravilo prejemale 3 mesece ali več, so opazili razvoj žarišč spremenjenih hepatocitov (FAH) in hepatoceličnih tumorjev.
English: Hepatobiliary disorders blood alkaline phosphatase increased, aspartate aminotransferase increased, alanine aminotransferase increased, blood bilirubin increased (including hyperbilirubinaemia), liver function test abnormal hepatic failure (see section 4.4), gammaglutamyltransferase increased, jaundice, cholestasis, hepatomegaly, hepatitis hepatocellular damage including fatal cases (see section 4.4)
Slovenian: 4.4), povečanje vrednosti gamaglutamiltransferaze, zlatenica, holestaza, hepatomegalija, hepatitis hepatocelularne okvare, vključno s smrtnimi primeri (glejte poglavje 4.4)
English: Using aseptic techniques at room temperature, Mycamine is reconstituted and diluted as follows:
Slovenian: Zdravilo Mycamine je treba pripraviti za uporabo z upoštevanjem aseptičnih postopkov pri sobni temperaturi po naslednjih navodilih:
English: OTHER
Slovenian: NE
English: Children (including neonates) and adolescents < 16 years of age: - Treatment of invasive candidiasis.
Slovenian: Otroke (vključno z novorojenčki) in mladostnike, mlajše od 16 let:
English: Prescriber checklist
Slovenian: KLINIČNI PODATKI
English: Cases of serious hepatic dysfunction occurred uncommonly (see section 4.4).
Slovenian: preobčutljivost anafilaktični in anafilaktoidni šok (glejte poglavje 4.4)
English: Preparation of the solution for infusion
Slovenian: POSTOPEK UPORABE DATUM IZTEKA ROKA UPORABNOSTI ZDRAVILA
English: 31 May 2016 EMA/270540/2016
Slovenian: 31. maj 2016 EMA/270540/2016
English: Although a possible effect in decreasing gingivitis was observed, information on how the study was conducted is incomplete, so firm conclusions could not be drawn.
Slovenian: Čeprav je bil zaznan možen učinek pri zmanjševanju gingivitisa, so podatki o načinu izvedbe študije pomanjkljivi, zato trdnih zaključkov ni bilo možno sprejeti.
English: Knotgrass herb medicines should only be used in adults and adolescents over the age of 12 years.
Slovenian: Zdravila, ki vsebujejo zel ptičje dresni, se smejo uporabljati samo pri odraslih in mladostnikih, starejših od 12 let.
English: In its assessment, the HMPC considered a clinical study in men with gingivitis (inflammation of the gum).
Slovenian: V svoji oceni je odbor HMPC upošteval klinično študijo pri moških z gingivitisom (vnetjem dlesni).
English: This summary is not intended to provide practical advice on how to use medicines containing knotgrass herb.
Slovenian: Povzetek ni namenjen zagotavljanju praktičnih nasvetov o uporabi zdravil, ki vsebujejo zel ptičje dresni.
English: Further information on the risks associated with knotgrass herb medicines, including the appropriate precautions for their safe use can be found in the monograph under the tab ‘All documents' on the Agency's website: ema.europa.eu/Find medicine/Herbal medicines for human use.
Slovenian: Dodatne informacije o tveganjih, povezanih z zdravili, ki vsebujejo zel ptičje dresni, vključno z ustreznimi previdnostnimi ukrepi za njihovo varno uporabo, so na voljo v monografiji na spletni strani agencije pod zavihkom „Vsi dokumenti“: ema.europa.eu/Find medicine/Herbal medicines for human use.
English: However, because of the limitations with the available data, the HMPC conclusions on the use of these knotgrass herb medicines are based on their long-standing use.
Slovenian: Vendar zaradi pomanjkljivosti razpoložljivih podatkov zaključki odbora HMPC v zvezi z uporabo zdravil, ki vsebujejo zel ptičje dresni, temeljijo na njihovi dolgotrajni uporabi.
English: The HMPC also considered studies in laboratory tests which support anti-inflammatory and antibacterial effects of knotgrass herb medicines.
Slovenian: Odbor HMPC je prav tako upošteval študije z laboratorijskimi preskusi, ki podpirajo protivnetne in protibakterijske učinke zdravil, ki vsebujejo zel ptičje dresni.
English: Knotgrass herb is the common name for the flowering aerial parts of the plant Polygonum aviculare L. The HMPC conclusions only cover knotgrass herb preparations which are obtained by drying and comminuting (reducing into tiny pieces) the flowering aerial parts.
Slovenian: Zel ptičje dresni je splošno ime za cvetoče nadzemne dele rastline Polygonum aviculare L. Zaključki odbora HMPC zajemajo samo pripravke z zeljo ptičje dresni, ki se pridobivajo s sušenjem in drobljenjem (zmanjševanjem na majhne delce) cvetočih nadzemnih delov.
English: This is a summary of the scientific conclusions reached by the Committee on Herbal Medicinal Products (HMPC) on the medicinal uses of knotgrass herb.
Slovenian: To je povzetek znanstvenih zaključkov Odbora za zdravila rastlinskega izvora (HMPC) v zvezi z medicinsko uporabo zeli ptičje dresni.
English: Information on the use and licensing of knotgrass herb medicines in EU Member States should be obtained from the relevant national authorities.
Slovenian: Za informacije o uporabi in registraciji zdravil, ki vsebujejo zel ptičje dresni, v državah članicah EU se obrnite na pristojni nacionalni organ.
English: Any applications for the licensing of medicines containing knotgrass herb have to be submitted to the national authorities responsible for medicinal products, which will assess the application for the herbal medicine and take into account the scientific conclusions of the HMPC.
Slovenian: Vlogo za izdajo dovoljenja za promet z zdravili, ki vsebujejo zel ptičje dresni, je treba predložiti pristojnemu nacionalnemu organu za zdravila, ki bo to vlogo za izdajo dovoljenja za promet z zdravilom rastlinskega izvora ocenil in upošteval znanstvene zaključke odbora HMPC.
English: Further information on the HMPC assessment of knotgrass herb medicines, including details of the Committee's conclusions can be found under the tab ‘All documents' on the Agency's website: ema.europa.eu/Find medicine/Herbal medicines for human use.
Slovenian: Dodatne informacije o oceni zdravil, ki vsebujejo zel ptičje dresni, ki jo je opravil odbor HMPC, vključno z njegovimi znanstvenimi zaključki, so na voljo na spletni strani agencije pod zavihkom „Vsi dokumenti“: ema.europa.eu/Find medicine/Herbal medicines for human use.
English: How are knotgrass herb medicines approved in the EU?
Slovenian: Kako so zdravila, ki vsebujejo zel ptičje dresni, odobrena v EU?
English: The HMPC conclusions are taken into account by EU Member States when evaluating applications for the licensing of herbal medicines containing knotgrass herb.
Slovenian: Ugotovitve odbora HMPC države članice EU upoštevajo pri ocenjevanju vlog za izdajo dovoljenja za promet z zdravili rastlinskega izvora, ki vsebujejo zel ptičje dresni.
English: Herbal medicines containing these knotgrass herb preparations are usually available as herbal material that is used to make herbal teas to be drunk or added to water to produce a liquid (decoction) to be applied to the lining of the mouth.
Slovenian: Zdravila rastlinskega izvora, ki vsebujejo te pripravke z zeljo ptičje dresni, so navadno na voljo kot rastlinski material za pripravo zdravilnih čajev, ki se popijejo, ali za dodajanje v vodo, da nastane tekočina (prevretek), ki se nanese na ustno sluznico.
English: Knotgrass herb preparations may also be found in combination with other herbal substances in some herbal medicines.
Slovenian: Pripravki z zeljo ptičje dresni so v nekaterih zdravilih rastlinskega izvora lahko na voljo tudi v kombinaciji z drugimi rastlinskimi snovmi.
English: The HMPC concluded, that on the basis of its long-standing use, these knotgrass herb preparations can be used for the relief of symptoms of common cold, for treating symptoms of minor mouth or throat inflammation and for minor problems affecting the urinary tract (structures that carry urine) to increase the production of urine in order to achieve flushing of the urinary tract.
Slovenian: Odbor HMPC je na podlagi dolgotrajne uporabe zaključil, da se lahko ti pripravki, ki vsebujejo zel ptičje dresni, uporabljajo za lajšanje simptomov prehlada, za zdravljenje simptomov blažjega vnetja ust ali grla in za blažje težave s sečili (strukturami za odvajanje seča (urina)), tako da povečajo tvorbo seča, kar omogoči izpiranje sečil.
English: The HMPC conclusions on the use of these knotgrass herb medicines for common colds, minor mouth or throat inflammation and minor problems affecting the urinary tract are based on their ‘traditional use'.
Slovenian: Zaključki odbora HMPC v zvezi z uporabo zdravil, ki vsebujejo zel ptičje dresni, za prehlad, blažje vnetje ust ali grla in blažje težave s sečili temeljijo na njihovi „tradicionalni uporabi“.
English: If symptoms last longer than two weeks or worsen during the use of the medicine for minor urinary tract problems a doctor or qualified healthcare practitioner should be consulted.
Slovenian: Če simptomi med uporabo zdravila pri blažjih težavah s sečili trajajo dlje kot dva tedna ali se poslabšajo, se je treba posvetovati z zdravnikom ali usposobljenim zdravstvenim delavcem.
English: For more information about treatment with knotgrass herb medicines, read the package leaflet that comes with the medicine or contact your doctor or pharmacist.
Slovenian: Za več informacij o zdravljenju z zdravili, ki vsebujejo zel ptičje dresni, preberite navodilo za uporabo, ki je priloženo posameznemu zdravilu, ali se posvetujte z zdravnikom ali farmacevtom.
English: Detailed instructions on how to take knotgrass herb medicines and who can use them can be found in the package leaflet that comes with the medicine.
Slovenian: Podrobna navodila o jemanju zdravil, ki vsebujejo zel ptičje dresni, in o tem, kdo sme ta zdravila jemati, so na voljo v navodilu za uporabo, ki je priloženo posameznemu zdravilu.
English: If symptoms last longer than one week or worsen during the use of the medicine for common cold symptoms or for minor mouth or throat inflammation, a doctor or qualified healthcare practitioner
Slovenian: Če simptomi med uporabo zdravila pri prehladu ali blažjem vnetju ust ali grla trajajo dlje kot en teden ali se poslabšajo, se je treba posvetovati z zdravnikom ali usposobljenim zdravstvenim
English: For practical information about using knotgrass herb medicines, patients should read the package leaflet that comes with the medicine or contact their doctor or pharmacist.
Slovenian: Za praktične informacije o njihovi uporabi naj bolniki preberejo navodilo za uporabo, ki je priloženo posameznemu zdravilu, ali se posvetujejo z zdravnikom ali farmacevtom.
English: What is knotgrass herb?
Slovenian: Kaj je zel ptičje dresni?
English: What evidence supports the use of knotgrass herb medicines?
Slovenian: Kateri dokazi podpirajo uporabo zdravil, ki vsebujejo zel ptičje dresni?
English: What are the risks associated with knotgrass herb medicines?
Slovenian: Kakšna tveganja so povezana z zdravili, ki vsebujejo zel ptičje dresni?
English: should be consulted.
Slovenian: delavcem.
English: Other information about knotgrass herb medicines
Slovenian: Druge informacije o zdravilih, ki vsebujejo zel ptičje dresni
English: Neupro rotigotine
Slovenian: Neupro rotigotin
English: The European Commission granted a marketing authorisation valid throughout the European Union for Neupro on 15 February 2006.
Slovenian: Evropska komisija je dovoljenje za promet z zdravilom Neupro, veljavno po vsej Evropski uniji, odobrila dne 15. februarja 2006.
English: The full EPAR for Neupro can be found on the Agency's website ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
Slovenian: Celotno evropsko javno poročilo o oceni zdravila (EPAR) za zdravilo Neupro je na voljo na spletni strani agencije ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
English: What is the risk associated with Neupro?
Slovenian: Kakšna tveganja so povezana z zdravilom Neupro?
English: What benefit has Neupro shown during the studies?
Slovenian: Kakšne koristi je zdravilo Neupro izkazalo med študijami?
English: This is a summary of the European public assessment report (EPAR) for Neupro.
Slovenian: To je povzetek evropskega javnega poročila o oceni zdravila (EPAR) za zdravilo Neupro.
English: Neupro is used when a specific cause for the disorder cannot be identified.
Slovenian: Zdravilo Neupro se uporablja, kadar točnega vzroka motnje ni mogoče ugotoviti.
English: Other information about Neupro
Slovenian: Druge informacije o zdravilu Neupro
English: Neupro was less effective than ropinirole: an improvement was seen in 70% of the patients receiving ropinirole.
Slovenian: Zdravilo Neupro je bilo manj učinkovito od ropinirola: izboljšanje je bilo opaženo pri 70 % bolnikov, ki so prejemali ropinirol.
English: For more information about treatment with Neupro, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Slovenian: Za več informacij o zdravljenju z zdravilom Neupro preberite navodilo za uporabo (ki je prav tako del EPAR) ali se posvetujte z zdravnikom ali farmacevtom.
English: It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for Neupro.
Slovenian: Pojasnjuje, kako je Odbor za zdravila za uporabo v humani medicini (CHMP) ocenil zdravilo Neupro, na podlagi česar je oblikoval mnenje za odobritev dovoljenja za promet z njim in priporočila glede pogojev njegove uporabe.
English: The CHMP decided that Neupro's benefits are greater than its risks and recommended that it be given marketing authorisation.
Slovenian: CHMP je zaključil, da so koristi zdravila Neupro večje od z njim povezanih tveganj, in priporočil, da se zanj odobri dovoljenje za promet.
English: The backing layer of Neupro contains aluminium.
Slovenian: Vrhnja plast obliža Neupro vsebuje aluminij.
English: Neupro is used to treat the symptoms of the following diseases in adults:
Slovenian: Zdravilo Neupro se uporablja za zdravljenje odraslih s simptomi naslednjih bolezni:
English: Neupro is applied once a day at about the same time every day.
Slovenian: Obliž zdravila Neupro se namesti enkrat dnevno, vsak dan ob približno istem času.